ExamPat

ELMORE PATENT LAW GROUP, P.C.

Patent reexamination counsel·3 ex parte reexams

ELMORE PATENT LAW GROUP, P.C. has served as patent-owner counsel in 3 USPTO ex parte reexaminations. The firm most often represents Massachusetts Institute of Technology and POINT Biopharma, Inc.. ExamPat indexes the full prosecution record for each proceeding, including office-action grounds, certificate outcomes, and downstream PTAB and Federal Circuit decisions.

Filings by year

2
15
1
22

Top patent owners represented

Outcome track record

How this firm's reexams resolve once a certificate issues: all claims confirmed, amended, mixed, or canceled.

  • Certificate outcome split across every bucket
  • Share of proceedings where claims survived

Practice metrics

Certificate rate, average pendency, and the open/closed split across the firm's full reexam docket.

  • Certificate rate of closed proceedings
  • Average pendency in months

Examiners & adversaries

Which examiners most often decide this firm's reexams, and which requesters most often challenge its patents.

  • Most frequent examiners
  • Top opposing requesters

Recent reexaminations (3)

Control #FiledPatentTitleOwnerStatus
90/015,012Apr 21, 202211,129,912RADIOPHARMACEUTICAL AND METHODSPOINT Biopharma, Inc.Closed
90/013,534Jun 25, 20155,670,483STABLE MACROSCOPIC MEMBRANES FORMED BY SELF-ASSEMBLY OF AMPHIPHILIC PEPTIDES AND USES THEREFORMassachusetts Institute of TechnologyClosed
90/013,535Jun 25, 20155,955,343STABLE MACROSCOPIC MEMBRANES FORMED BY SELF-ASSEMBLY OF AMPHIPHILIC PEPTIDES AND USES THEREFORMassachusetts Institute of TechnologyClosed

Other reexam law firms

See the full reexam picture for ELMORE PATENT LAW GROUP, P.C.

Certificate outcomes, pendency, and the parties and examiners behind these cases. Free to sign up.